HomeTherapeutic areasOncology › Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia (4 companies)

Companies with an active program in Acute Lymphoblastic Leukemia.

Ticker Company Therapeutic areas Programs Lead stage Programs
ARTV Artiva Biotherapeutics DermatologyImmunology+2 Rare 1 Phase 2 14
AUTL Autolus Therapeutics HematologyImmunology+3 Rare 3 Approved 12
KURA Kura Oncology MetabolicOncology 1 Approved 12
SLS SELLAS Life Sciences Group Oncology 1 Phase 3 9